Search

everythinglearnresearchcommunity

for

Search:↓

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Azathioprine may be an effective treatment for severe hair loss.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Apremilast may help treat hair loss in alopecia areata.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Men with Addison disease should be screened for X-linked adrenoleukodystrophy if they have hair loss.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.